SANDIMMUNE IN STABLE RENAL TRANSPLANT PATIENTS WHO ABSORB CYCLOSPORINE POORLY

SANDIMUNE 用于环孢素吸收不良的稳定肾移植患者

• 批准号: 6274764
• 负责人: ALAN B LEICHTMAN
• 金额: $ 2.15万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6274764
• 关键词: clinical research; cyclosporines; dosage forms; drug screening /evaluation; gastrointestinal drug absorption; human subject; human therapy evaluation; immunosuppression; kidney transplantation; malabsorption; oral administration; pharmacokinetics

This study is being performed to determine if Sandimmune oral solution and Sandimmune soft gelatin capsules are bioequivalent in stable renal transplant recipients who absorb cyclosporine poorly.

本研究旨在确定Sandimmune口服液 和Sandimmune软明胶胶囊在稳定的肾脏中具有生物等效性 移植受者对环孢霉素吸收不良。